Facebook
X
LinkedIn
Forward
Session 9: Cancer Precision Medicine
This course will give an overview of Cancer Precision Medicine and Precision Therapeutics in healthcare today.
Deepak Kilari, MD, practices at the Froedtert & the Medical College of Wisconsin Clinical Cancer Center where he specializes in the management of patients with genitourinary malignancies. Dr. Kilari moved back to the United States after finishing medical school in India to finish his internal medicine training at New York Methodist Hospital. In the course of his residency, he developed an interest in Oncology during his rotations at the Memorial Sloan Kettering Cancer Center in New York. Subsequently he completed a fellowship in hematology and oncology at the University of Rochester, where he also served as a Chief Fellow. He received the ASCO foundation Merit award in 2013. His clinical research interests focus on the development of better treatment options for patients with genitourinary malignancies
Target Audience
- Physicians
- Nurse Practitioners
- Physician Assistants
- Pharmacists
- Genetic Counselors
- Researchers
- Lab Technicians
Learning Objectives
Participants who engage in this education intervention will be able to:
- Indicate cancer therapy targets in the somatic and germline genome.
- Identify the differential functional and therapeutic significance of genomic alterations in a context dependent fashion.
- Summarize the relevance of spatiotemporal heterogeneity and clonal evolution as it pertains to targeted therapy in cancer.
This module is presented with a pre-recorded PowerPoint presentation and sound. An audio lecture is given using visual key points listed on the PowerPoint presentation. Following the presentation, learners will be asked quiz questions to test retainment of knowledge gained in the presentation. Learners are able to complete the module at their own pace.
Jennifer Geurts, MS, CGC
- Carolyn Oxencis
- Donald Basel
- Gwen Lomberk
- Jake Luo
- Jennifer Geurts
- Jeremy Garrett
- John Meurer
- Michael Zimmerman
Name | Company | Role |
Deepak Kilari, MD | Eisai, Aveo, Jannsen, Pfizer, Exelixis, MJH Life Science, Aptitude, Targeted Oncology | Consultant, Speaker, Advisory Board |
Accreditation Statement
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit Statement
The Medical College of Wisconsin designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.50 hours of participation for continuing education for allied health professionals.
The National Society of Genetic Counselors (NSGC) has authorized The Medical College of Wisconsin to offer up to 1.5 CEUs or 15 Category 1 contact hours for the activity Precision Medicine Continuing Education Program Spring 2025. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor recertification.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation shared with ABP through PARS:
Individual participants’ information will be shared with ABP through the ACCME Program and Activity Reporting System (PARS).
Available Credit
- 1.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.50 Hours of ParticipationHours of Participation credit.